• SENSEX 77,062.85
    145.00 (+0.19%)
  • BANKNIFTY 55,540.05
    537.85 (+0.98%)
  • NSE
    1,824.90 1,878.00(%)
  • SBI Life Insuran
    1,704.10 2,132.90(%)
  • BLS Polymers
    288.00 285.25(%)
  • SFC Enviro.
    478.20 424.85(%)
  • Multi Comm. Exc.
    3,252.50 1,761.43(%)
  • ITC
    283.50 421.70(%)
  • Jio Platforms
    1,424.65 1,356.40(%)
  • HDFC Bank
    741.00 1,017.90(%)
  • Info Edg.(India)
    1,159.40 909.20(%)
  • Reliance Industries
    1,296.20 1,152.30(%)
  • Godrej Consumer
    851.20 1,275.00(%)
  • Bharti Airtel
    2,042.90 1,726.05(%)
  • SBI
    987.75 1,234.80(%)
  • Welspun Corp
    2,360.00 2,899.95(%)
  • Welspun Living
    267.40 257.00(%)
  • Saregama India
    576.95 574.85(%)
  • KRN Heat Exchan
    982.95 589.75(%)
  • Billionbrains
    209.90 227.00(%)
  • Fractal Analyt.
    834.60 1,119.60(%)
  • Vedanta Aluminium Metal
    362.90 538.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Jubilant Pharmova Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Jubilant Bhartia
  • BSE Code : 592.0
  • ISIN : INE700A01033
938.75 -8 (-0.84%)
  • As on 04 Nov 2026 (EOD)

  • Today’s Low

    936.05

  • Today’s High

    956.00

  • Open

    949.00

  • Perv Close

    946.75

  • 52W Low

    786.05

  • 52W High

    1,183.00

Key Indicators

  • P/E(TTM)

    473.99

  • Mar.Cap (₹Cr.)

    14,954.29

  • Div & Yield %

    0.53

  • Book Value(₹)

    145.16

  • Debt-Equity Ratio

    -0.84

  • AGM Date

    03-Nov-2026

  • EPS

    1.98

  • P/E Ratio

    473.99

Financials Ratios

  • Debt-Equity Ratio

    0.68

  • Mar.Cap (₹Cr.)

    14,954.29

  • RONW (%)

    0.76

  • ROCE (%)

    6.37

Score Board

  • Equity (₹ in Cr.)

    15.93

  • BV (₹)

    145.20

  • Sales( ₹ in Cr.)

    263.50

  • NP (in Cr.)

    70.84

  • NP Var(%)

    219.0

  • Div%

    500.0

  • CPS (₹)

    4.80

  • EPS (₹)

    4.40

  • Traded Value (₹ in Lakhs)

    14,950.31

  • 52 Week High

    1,183.00

  • 52 Week Low

    786.05

  • Price BSE

    939.0

  • Price NSE

    939.00

  • Market Capital( in Cr.)

    14,950.31

  • P/C Ratio

    194.70

  • P/E Ratio

    211.10

  • Price Vs.BV

    4.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 263.50 231.40 784.70 810.10 725.73 2,709.50
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 263.50 231.40 784.70 810.10 725.73 2,709.50
Other Income 45.70 20.20 103.40 137.90 126.16 47.88
Stock Adjustments 0.00 0.00 -39.00 -3.50 40.61 -55.21
Total Income 309.20 251.60 849.10 944.50 892.50 2,702.17
EXPENDITURE :            
Raw Materials 0.00 0.00 316.50 411.10 372.89 1,395.15
Power and Fuel Cost 26.20 23.70 68.40 75.40 62.31 280.40
Employee Cost 103.80 92.10 190.00 167.30 163.64 220.67
Other Manufacturing Expenses 25.60 22.80 59.60 49.00 39.80 216.91
Selling and Administration Expenses 55.40 48.60 88.60 93.00 111.59 100.02
Miscellaneous Expenses 12.40 6.50 6.10 7.70 9.65 14.07
Employee Benefit Expenses 103.80 92.10 190.00 167.30 163.64 220.67
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 223.40 193.70 729.20 803.50 759.88 2,227.23
Operating Profit 85.80 57.90 119.90 141.00 132.62 474.94
Interest 7.30 12.90 29.90 18.50 10.99 101.80
Gross Profit 78.50 45.00 90.00 122.50 121.63 373.14
Depreciation 6.00 6.60 48.30 43.20 36.91 99.97
Profit Before Tax 72.50 38.40 41.70 79.30 84.72 273.17
Current Tax 4.60 20.50 6.80 13.80 14.28 45.44
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.70 -1.30 3.30 15.60 -10.05 13.25
Reported Net Profit 63.20 19.20 31.60 49.90 80.49 214.48
Extraordinary Items -7.64 -3.00 -0.76 0.25 0.02 -0.19
Adjusted Net Profit 70.84 22.20 32.36 49.65 80.47 214.67
Adjustment below Net Profit 5.40 3.30 0.00 -0.70 0.81 -212.82
P & L Balance brought forward 1,018.50 1,075.60 1,123.60 1,154.00 1,152.37 1,153.26
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 79.60 79.60 79.60 79.60 79.64 0.00
P & L Balance carried down 1,007.50 1,018.50 1,075.60 1,123.60 1,154.03 1,154.92
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 500.00 500.00 500.00 500.00 500.00 500.00
Dividend Per Share(Rs) 5.00 5.00 5.00 5.00 5.00 5.00
Earnings Per Share-Unit Curr 3.97 1.21 1.99 3.14 5.05 13.46
Earnings Per Share(Adj)-Unit Curr 3.97 1.21 1.99 3.14 5.05 13.46
Book Value 145.43 145.79 149.34 151.86 153.11 80.51
Book Value(Adj)-Unit Curr 145.43 145.79 149.34 151.86 153.11 80.51

Shareholding Pattern

  • Promoter Group

    47.68%

  • Public Share Holding

    51.78%

  • Custodian

    0.55%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 5,230,455 3.28 5,230,455 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 5,000 5,000.00 5,000 5,000
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 5,235,455 3.29 5,235,455 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 68,804,742 43.20 68,804,742 5
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,898,425 1.19 1,898,425 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 70,703,167 44.39 70,703,167 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 2,645 0.00 2,045 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 24,492,626 15.38 24,492,626 146
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1,706,087 1.07 1,706,087 1
Mutual Funds / UTI 15,008,801 9.42 15,008,801 17
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 4,017,613 2.52 4,017,613 17
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 45,227,772 28.39 45,227,172 183
2] Non Institution
Bodies Corporate 4,914,686 3.09 4,914,686 730
Clearing Members 130,910 0.08 130,910 25
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,979,737 1.24 1,958,722 2,523
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 597,777 0.38 597,777 1,481
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 10,244,000 6.43 10,244,000 2
Individuals holding nominal share capital up to Rs. 1 lakh 16,889,904 10.60 16,605,559 77,525
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 28,010 0.02 28,010 7
Others 1,974,972 1.24 1,974,972 1
Sub Total 37,242,180 23.38 36,936,820 82,407
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 872,565 0.55 872,565 1
Total Shares held by Custodians and against which Depository Receipts have been issued 872,565 0.55 872,565 1
Grand Total ( A + B + C ) 159,281,139 100.00 158,975,179 82,602

Company Background

Jubilant Pharmova LtdPharmaceuticals - Indian - Bulk Drugs

  • Jubilant Pharmova Ltd
  • BSE Code : 592.0
  • ISIN : INE700A01033

  • Incorporation Year

    1978

  • Registered Office

    Bhartiagram Gajraula
    , Amroha,
    Uttar Pradesh-244223

  • Telephone

    91-5924-267200

  • FAX

    91-5924-4264895/96

  • Chairman

    Shyam S Bhartia

  • Managing Director

    Priyavrat Bhartia

  • Company Secretary

    Naresh Kapoor

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Alankit Assignments Ltd
    Alankit Heights ,
    1E/13 Jhandewalan Ex,
    Mumbai - New Delhi-110055

Jubilant Pharmova Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Jubilant Pharmo 938.50 265.90 263.50 231.16 1.79
Abbott India 25,805.30 7,217.19 6,929.05 33.96 43.78
Astrazeneca Phar 6,340.60 2,304.07 2,275.58 93.45 27.86
Glaxosmi. Pharma 2,573.30 3,932.76 3,790.20 41.11 58.17
Novartis India 1,719.85 393.10 354.33 43.43 15.94
Cipla 1,392.20 20,102.60 18,979.95 42.43 13.88
Bliss GVS Pharma 637.90 773.53 729.81 41.58 12.51
Amrutanjan Healt 499.35 520.13 502.55 26.75 24.16
Fermenta Biotec. 427.55 474.15 450.25 19.96 18.77
Guj. Themis Bio. 377.25 168.25 165.82 100.87 18.05
Ambalal Sarabhai 34.90 19.52 3.94 64.63 6.77